FDA-approved
Hormones & metabolism
Pramlintide
Evidence
FDA approved
Class
Amylin analog
KEY TAKEAWAY
Pramlintide is a 37-amino-acid synthetic analog of amylin, a hormone released with insulin after meals. It is sold as Symlin. The FDA approved pramlintide (Symlin) in 2005 as an add-on to mealtime insulin.
Written by the Veylo editorial team · Updated
November 2026
What it is
Amylin analog
Approved for
Type 1 and type 2 diabetes in people who use mealtime insulin
Key fact
The FDA approved pramlintide (Symlin) in 2005 as an add-on to mealtime insulin.
Route
Subcutaneous injection before meals
Evidence strength
FDA approved
Pramlintide is a 37-amino-acid synthetic analog of amylin, a hormone released with insulin after meals. It is sold as Symlin.
It slows stomach emptying, reduces the release of glucagon after meals and increases fullness.
The FDA approved pramlintide (Symlin) in 2005 as an add-on to mealtime insulin.
Type 1 and type 2 diabetes in people who use mealtime insulin.
Severe low blood sugar is a boxed-warning risk when it is used with insulin. Nausea is common.
U.S. FDA prescribing information for Pramlintide. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.